corporate meetings |
||||||
|
News for 27-Apr-24 Source: MedicineNet Senior Health General Source: MedicineNet Senior Health General Source: MedicineNet Prevention and Wellness General Source: MedicineNet Prevention and Wellness General
|
The Best corporate meetings websiteAll the corporate meetings information you need to know about is right
here. Presented and researched by http://www.md-news.net. We've searched
the information super highway far and wide to provide you with the
best corporate meetings site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
corporate meetings
We will bet you have felt lost in your search for corporate meetings information, after all the net can seem like a labyrinth of misinformation about corporate meetings. Well do not worry, sit back, have a coffee, relax because you have finally found a web site which can service your corporate meetings needs. The sites are operated by gurus in the corporate meetings field but on the off chance that the sites do not provide you with the corporate meetings information you are looking for, please come back and navigate through the menu on the right. corporate meetings
Here’s all you need to know about corporate meetingsThere is a great deal of information both in print and on the Internet about corporate meetings and some is good while some is not very good. It’s difficult to tell just what information is valid and of real value. We have spent a great deal to time and research in locating the very best corporate meetings web sites available. As you spend a few minutes with us you will see that we have a very comprehensive index of corporate meetings information and any question you have can be answered here. We know that your time is valuable and have made this corporate meetings resource site easy to navigate. If you have not already clicked the links in the middle of this page for more corporate meetings information we invite you to do so now. You will find them most valuable and the corporate meetings sources guarantee your satisfaction. Just in the event that the sites in the middle of this page are not exactly what you want, then please scroll down the corporate meetings links on the left side of the page and we are absolutely certain you will have every corporate meetings question answered. -Saving Pediatric Drug Becomes Readily Available to Those in Need by: ARA Content
(ARA) - We can all sympathize with the frustration people experience waiting for a new drug that is being tested for a certain disorder. Imagine you have a child with a rare disorder and the only drug effective for treating the disorder is not only extremely hard to obtain, but available only through a nationally-administered random selection process. For many American families, this dilemma is a harsh reality. Patients suffering from a host of difficult to treat orphan disorders have found marked relief from using HP Acthar Gel. Some disorders Acthar helps include seizure complex in babies and young children, referred to as West's syndrome or infantile spasm; Still's disease and ulcerative colitis; Bell's palsy; multiple sclerosis; adrenocortical insufficiency and non-endocrine disorders that are responsive to glucocorticoids. For the past four years, however, the drug has only been available through a limited access program administered by the National Organization for Rare Disorders (NORD), a federation of more that 135 non-profit health organizations serving people with rare disorders. U.S. physicians who were interested in obtaining Acthar Gel for their patients with life-threatening or severely debilitating conditions who did not respond to any other treatment were given first access to the drug. Others with "non-life-threatening" cases had to enroll in a computerized random selection process administered by NORD. An estimated 1,600 patients, primarily suffering from West's syndrome and multiple sclerosis who experience episodes of "flare," have been allowed access to HP Acthar Gel each year for the past four years under the limited access program. More than 5,000 additional patients whose physicians requested the drug were denied. The origins of this drug shortage crisis date back to 1996 when Aventis Pharmaceuticals stopped making Acthar for a few months because of manufacturing difficulties. But now, Questcor Pharmaceuticals, Inc. (AMEX: QSC) has signed an agreement with Aventis to acquire the worldwide rights to HP Acthar Gel. Questcor has also reached a manufacturing agreement with Aventis and will gradually move production to an independent manufacturing facility. As a result, HP Acthar Gel is now back in full production and is returning to normal levels of distribution. Questcor began shipments of HP Acthar Gel to wholesalers the last week of September 2001, giving patients in need access to the product. "We are delighted that Questcor is making this critically important product more widely available after this long period of restricted distribution," said Abbey S. Meyers, president of NORD. "We have been working closely with the company over the last several months to ensure that anyone with a need for Acthar Gel is now able to readily receive the product through more traditional channels. Too many people have suffered as a result of limited access to Acthar Gel." Questcor Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company that serves the needs of acute and critical care hospitals with its proprietary products. Visit www.questcor.com for more information on the company and its products. If you are a patient with a disorder that can be treated with Acthar, ask your doctor to contact Questcor Pharmaceuticals at (510) 400-0700. For more information about Acthar, including distribution information, please visit www.Acthar.com.
|
|||||
|
http://www.medmeet.com/ |
||||||
| Real Time Media On The Net MD Newscast Medical Presentations |